A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

NCT04179045 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

785

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

Sponsor

Shanghai Bio-heart Biological Technology Co., Ltd.

Collaborators

[object Object]